For the first time the RIMLS PhD council organized the Supervisor election wih many nominees. This year's winner is Ronald van Rij.
The PhD council invited PhD candidates to anonymously submit three reasons why their supervisors deserved to become the superhero of the RIMLS. The reasons were anonimised and we asked several judges to rank. The three best-ranked supervisors were: Jack Schalken, Alessandra Cambi and Ronald van Rij. Then, we opened a period when everyone could vote for one supervisor. There were some very enthusiastic campaigns going on: We’ve had no less than 250 unique votes!
We hope that this competition will become a fun and inspiring tradition at the RIMLS. On November, 2018 we will call for nominations again, so be alert and take the new chance to acknowledge the value of our daily superheroes. Excellence is shown in many ways, and excellent supervision is something we should all strive for!
Click here for all the photos of the New Year's Drinks.
Ronald received an award and a hoody.
Related news items
New ultra-high field MRI system available for Radboudumc and Radboud University10 June 2021
Recently, the Hahn institute in Essen has received a new heart: a 20-ton ultra-high-field MRI scanner from Siemens Healthcare with a magnetic field strength of 7 Tesla. The new CE-approved scanner is ready for business, and projects on body and brain imaging are starting up.read more
On the prevalence of cerebral amyloid angiopathy a systematic review and meta-analysis10 June 2021
Published in ‘Alzheimers and Dementia’, researchers at Radboudumc performed a systematic review and meta-analysis on the prevalence of Cerebral Amyloid Angiopathy. They scrutinized and analyzed 170 publications, comprising publications using either a neuroimaging or a neuropathological approach.read more
Retina-on-chip modeling and treating eye diseases in a dish10 June 2021
Alex Garanto, together with Anneke den Hollander and Andries van der Meer (UTwente) have received 1,17M€ to develop a retina-on-chip model to improve our understanding in eye diseases and to develop treatments against them.read more
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses8 June 2021
Jeroen Creemers and Johannes Textor published in the Journal for ImmunoTherapy of Cancer that a tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery.read more
New method to prevent ovarian cancer increases quality of life8 June 2021
Researchers at Radboudumc have shown that quality of life is better in women with a BRCA1 or BRCA2 mutation after fallopian tube removal with delayed ovarian removal to prevent ovarian cancer.read more